Eton Pharmaceuticals (ETON) EBIAT (2019 - 2025)
Historic EBIAT for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to -$1.9 million.
- Eton Pharmaceuticals' EBIAT fell 40733.65% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.7 million, marking a year-over-year decrease of 2191.21%. This contributed to the annual value of -$3.8 million for FY2024, which is 30844.02% down from last year.
- According to the latest figures from Q3 2025, Eton Pharmaceuticals' EBIAT is -$1.9 million, which was down 40733.65% from -$2.6 million recorded in Q2 2025.
- Over the past 5 years, Eton Pharmaceuticals' EBIAT peaked at $5.1 million during Q1 2021, and registered a low of -$9.0 million during Q4 2022.
- Its 5-year average for EBIAT is -$1.7 million, with a median of -$1.9 million in 2025.
- As far as peak fluctuations go, Eton Pharmaceuticals' EBIAT plummeted by 96823.87% in 2022, and later surged by 39261.87% in 2023.
- Over the past 5 years, Eton Pharmaceuticals' EBIAT (Quarter) stood at $1.0 million in 2021, then crashed by 968.24% to -$9.0 million in 2022, then surged by 74.99% to -$2.3 million in 2023, then soared by 73.49% to -$598000.0 in 2024, then tumbled by 222.24% to -$1.9 million in 2025.
- Its EBIAT was -$1.9 million in Q3 2025, compared to -$2.6 million in Q2 2025 and -$1.6 million in Q1 2025.